Enara Bio Appoints Stacey Davis as Chief Business and Financial Officer
Enara Bio, a UK-based biotechnology company developing T-cell immunotherapies targeting novel "Dark Antigens" in solid tumours, has announced the appointment of... Read more.
Merck to Acquire London Based Verona Pharma in £7.8 Billion Deal
Post 0 Share 0 Post 0 Verona Biotech, the London-based biotech company behind a breakthrough treatment for chronic obstructive pulmonary disease (COPD), has been... Read more.
Healx partners with SCI Ventures on paralysis research
Post 0 Share 0 Post 0 Cambridge-based biotech firm has entered into a new partnership with a specialist venture fund to explore treatments for paralysis using artificial... Read more.
Portal Biotech secures £27.5 million NATO investment to counter bioengineered threats
Post 0 Share 0 Post 0 London-based life sciences startup, Portal Biotech has secured £27.5 million ($35 million) in Series A funding, led by the NATO Innovation... Read more.
AstraZeneca Lung Cancer ADC Approved by US Regulator
Post 0 Share 0 Post 0 The US Food and Drug Administration (FDA) has approved a new lung cancer treatment developed by AstraZeneca, the British–Swedish pharmaceutical... Read more.
UK Biotech OutSee raises £1.8m to expand AI-driven drug discovery
Post 0 Share 0 Post 0 Cambridge-based startup OutSee has secured £1.8 million in seed funding to accelerate its use of artificial intelligence in genomics for drug... Read more.
UK Launches OpenBind to Advance AI-Driven Drug Discovery
Post 0 Share 0 Post 0 The UK has launched a major open-science initiative, OpenBind, aimed at supporting the development of artificial intelligence in drug discovery.... Read more.
BioNTech to build UK research centres in £1bn cancer vaccine drive
Post 0 Share 0 Post 0 German biotech company BioNTech has confirmed a plan to invest up to £1 billion in the UK over the next decade, significantly expanding its... Read more.
Investors Back Welsh Biotech with £107M to Disrupt Depression Drug Market
Post 0 Share 0 Post 0 📍Cardiff - Draig Therapeutics has launched from stealth after raising $140 million (£107 million) in a Series A round. The Wales-based... Read more.
Maxion Therapeutics appoints Dr Stefan Härtle as CDO
Maxion Therapeutics has hired Dr Stefan Härtle as its new Chief Development Officer, a move that reflects the company’s push toward clinical development of its... Read more.